Back to Search
Start Over
A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
- Source :
-
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 1995 May; Vol. 95 (5 Pt 2), pp. 1117-22. - Publication Year :
- 1995
-
Abstract
- Intranasal ipratropium bromide has been shown to significantly reduce rhinorrhea. Use of a freon-propelled intranasal preparation has resulted in side effects associated with the drying properties of the propellant. The purpose of the present trial was to study the safety and efficacy of a new isotonic aqueous ipratropium bromide nasal spray pump, specifically in patients with perennial nonallergic rhinitis. Two hundred thirty-three patients participated in an 8-week double-blind parallel comparison of ipratropium bromide nasal spray with its vehicle, a saline solution. Treatment with the ipratropium spray resulted in a 30% reduction in rhinorrhea; this reduction was significantly greater than that seen with the saline vehicle. There was a modest reduction in postnasal drip, sneezing, and congestion with both treatments, which may be attributable to the salutary effects of the saline solution. Patients also perceived a significant reduction in the degree to which rhinorrhea interfered with their daily activities and moods. Treatment was well tolerated, with no drug-related systemic adverse events and no evidence of nasal rebound on discontinuation of treatment. Minor, infrequent episodes of nasal dryness and epistaxis were the only significant adverse events reported; these did not limit treatment.
Details
- Language :
- English
- ISSN :
- 0091-6749
- Volume :
- 95
- Issue :
- 5 Pt 2
- Database :
- MEDLINE
- Journal :
- The Journal of allergy and clinical immunology
- Publication Type :
- Academic Journal
- Accession number :
- 7751528
- Full Text :
- https://doi.org/10.1016/s0091-6749(95)70215-6